Benign lesions and mimics of malignancy in the thyroid gland

CPD Bulletin Cellular Pathology

Volumn 4, Issue 3, 2002, Pages 139-144

  Stephenson, Tim J ^a,b,c  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

A rtefacts; Degeneration; Hyperplasia; Metaplasia; Neoplasia; Pseudomalignancy; Thyroid

Indexed keywords

CYTOKERATIN; CYTOKERATIN 19; RADIOACTIVE IODINE;

BENIGN TUMOR; CANCER RADIOTHERAPY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL PRACTICE; MITOSIS; PAPILLARY CARCINOMA; POSTOPERATIVE CARE; REVIEW; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; THYROID HYPERPLASIA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

EID: 0036981227     PISSN: 14642506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Chan JKC, Tsang WYW. Endocrine malignancies that may mimic benign lesions. Semin Diagn Pathol 1995; 12: 45-63.
2. LiVolsi VA. Papillary neoplasms of the thyroid: Pathologic and prognostic factors. Am J Clin Pathol 1992; 97: 426-434.
3. Tielens ET, Sherman SI, Hruban RH, et al; Follicular variant of papillary thyroid carcinoma. Cancer 1994; 73: 424-431.
4. Damiani S, Fratamico F, Lapertosa G, et al; Alcian blue and epithelial membrane antigen are useful markers in differentiating benign from malignant papillae in thyroid. Virchows Archiv [A] 1991; 419: 131-135.
5. Stephenson TJ. Papillary carcinoma of the thyroid: A tumour still with no benign neoplastic counterpart. Histopathology 2001; 39: 536-538.
6. Kennedy JS. The pathology of dyshormonogenetic goitre. J Pathol 1969; 99: 251-264.
7. Lloyd RV, Douglas BR, Young WF editors: Endocrine Diseases. Fascicle 1 of Atlas of Nontumor Pathology, Washington 2001, American Registry of Pathology and Armed Forces Institute of Pathology, pp 91-169.
8. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the Thyroid Gland. Atlas of Tumor Pathology, Third Series Fascicle 5, Washington 1992, Armed Forces Institute of Pathology, Washington. pp 297-316.
9. Vickery AL. The diagnosis of malignancy in dyshormonogenetic goitre. Clin Endocrinol Metabolism 1981; 10: 317-335.
10. Stephenson TJ. Criteria for malignancy in endocrine tumours. Chapter 5, in: Anthony PP, MacSween RNM, Lowe DG (Eds.) Recent Advances in Histopathology 17. Edinburgh: Churchill Livingstone 1997, pp 93-111.
11. DeLellis RA. Orphan Annie eye nuclei: A historical note. Am J Surg Pathol 1993; 17: 1067-1068.
12. Chan JKC, Saw D. The grooved nucleus: A useful diagnostic criterion of papillary carcinoma of the thyroid. Am J Surg Pathol 1986; 10: 672-679.
13. Rosai J. Papillary carcinoma (Review). Monogr Pathol 1993; 35: 138-165.
14. Riazmontazer N, Bedayat G. Psammoma bodies in fine needle aspirates from thyroids containing nontoxic hyperplastic nodular goitres. Acta Cytologica 1991; 35: 563-566.
15. Cheung CC, Ezzat S, Freeman JL, et al; Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001; 14: 338-342.
16. Baloch ZW, Abraham S, Roberts S, et al; Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility. Hum Pathol 1999; 30: 1166-1171.
17. Mai KT, Landry DC, Thomas J, et al; Follicular adenoma with papillary architecture: A lesion mimicking papillary thyroid carcinoma. Histopathology 2001; 39: 25-32.
18. Mai KT, Ford JC, Yazdi HM, et al; Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules. Pathol Res Pract 2000; 196: 533-540.
19. Sack MJ, Astengo-Osuna C, Lin BT, et al; HBME-1 immunostaining in thyroid fine-needle aspirations: A useful marker in the diagnosis of carcinoma. Mod Pathol 1997; 10: 668-674.
20. Michiels FM, Billaud M. The Ret gene in thyroid pathology. Arch Anat Cytol Pathol 1998; 46: 2326-2333.
21. Fenton CL, Lukes Y, Nicholson D, et al; The Ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metabol 2000; 85: 1170-1175.
22. Fischer AH, Bond JA, Taysavang P, et al; Papillary thyroid carcinoma oncogene (Ret/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 1998; 153: 1443-1450.
23. Bounacer A, Wicker R, Caillou B, et al; High prevalence of activating Ret proto-oncogene rearrangements in thyroid tumors from patients who had received external radiation. Oncogene 1997; 15: 1263-1273.
24. Baker JR. Cytological Technique. London, 1950, Methuen, Ch 1, 1-21.
25. Anderson G. Enclosed tissue system problem. Institute for Medical Laboratory Sciences Gazette 1988; 32: 141-142.
26. Slater DN, Cobb N. Enclosed tissue processors. Institute for Medical Laboratory Sciences Gazette 1988; 32: 543-544.
27. Stansfeld AG. An introduction to biopsy interpretation. In Stansfeld, A.G., D'Ardenne A.J. (eds.) Lymph Node Biopsy Interpretation. Edinburgh, 1992, Churchill Livingstone, 50.
28. Stephenson TJ. Endocrine. Chapter 1 in: (editors) Al-Sam S, Lakhani SR, Davies JD. A Practical Atlas of Pseudomalignancy. London, 1998, Edward Arnold, pp 1-19.
29. Albores-Saavedra J, Altamirano-Dimas M, Alcorta-Anguizola B, et al; Fine structure of human papillary thyroid cancer. Cancer 1971; 28: 763-774.
30. Raphael SJ, McKeown-Eyssen G, Asa SL. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod Pathol 1994; 7: 295-300.
31. Fonseca E, Sobrinho-Simões M. Diagnostic problems in differentiated carcinomas of the thyroid. Pathol Update 1995; 2: 1-23.
32. Sobrinho-Simões M, Fonseca E. Recently described tumours of the thyroid. In: Anthony PP, MacSween RNM (eds) Recent Advances in Histopathology volume 16. Edinburgh, 1994, Churchill Livingstone, pp 213-229.
33. Sobrinho-Simões, M, Soares J, Carneiro F, et al; Diffuse follicular variant of papillary carcinoma of the thyroid: Report of eight cases of a distinct aggressive type of thyroid tumour. Surg Pathol 1990; 3: 189-203.
34. Carcangiu ML, Zampi G, Pupi A, et al; Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985; 55: 805-828.
35. Bell CD, Coire C, Treger T, et al; The "dark nucleus" and disruptions of follicular architecture: Possible new histological aids for the diagnosis of the follicular variant of papillary carcinoma of the thyroid. Histopathology 2001; 39: 33-42.
36. Hürthle K. Beitrage zur Kenntniss der Secretiononsvorgangs in der Schilddruse. Arch Gesamte Physiol 1894; 56: 1-44.
37. Askanazy M. Pathologisch-anatomisch Beitrage zur Kenntniss des Morbus Basedow, insbesondere uber die dabei auftretende Muskelerkranking. Dtsch Arch Klin Med 1898; 61: 118-186.
38. Ewing J. Neoplastic Diseases - A Textbook on Tumors. 1st edn. Philadelphia, 1919, Saunders
39. Carcangiu ML, Bianchi S, Savino D, et al; Follicular Hürthle cell tumors of the thyroid gland. Cancer 1991; 68: 1944-1953.
40. Bronner MP, LiVolsi VA. Oxyphilic (Askanazy/Hürthle cell) tumors of the thyroid: Microscopic features predict biologic behaviour. Surg Pathol 1988; 1: 137-150.
41. Tallini G, Carcangiu ML, Rosai J. Oncocytic neoplasms of the thyroid gland. Acta Pathol Jpn 1992; 42: 305-315.
42. Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 1987; 11: 593-601.
43. McCluggage WG, Sloan JM. Hyalinizing trabecular carcinoma of the thyroid gland. Histopathology 1996; 28: 357-362.
44. Sambade C, Fransilla K, Camasselle-Tejero J, et al; Hyalinizing trabecular adenoma: A misnomer for a peculiar tumor of the thyroid gland. Endocr Pathol 1991; 2: 83-91.
45. Gonzalez-Campora R, Fuentes-Vaamonde E, Hevia-Vasquez A, et al; Hyalinizing trabecular carcinoma of the thyroid gland: Report of two cases of follicular cell thyroid carcinoma with hyalinizing trabecular patterns. Ultrastruct Pathol 1998; 22: 557-563.
46. Fonseca E, Nesland J, Sobrinho-Simões M. Expression of stratified epithelial type cytokeratins in hyalinizing trabecular adenoma supports their relationship with papillary carcinoma of the thyroid. Histopathology 1997; 31: 330-335.
47. Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 2000; 24: 575-578.
48. Katoh R, Jasani B, Williams ED. Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology 1989; 15: 211-224.
49. Cheung CC, Boerner SL, MacMillan CM, et al; Hyalinizing trabecular tumor of thyroid: A variant of papillary carcinoma proven by molecular genetics. Am J Surg Pathol 2000; 24: 1622-1626.
50. Papotti, M, Volante M, Giuliano A, et al; Ret/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 2000; 24: 1615-1622.
51. LiVolsi VA. Hyalinizing trabecular adenoma of the thyroid: Adenoma, carcinoma, or neoplasm of uncertain malignant potential? Am J Surg Pathol 2000; 24: 1683-1684.